Experimental and clinical psychopharmacology · 2026
Pharmacological and sensorimotor mechanisms linking obsessive-compulsive symptoms and cigarette smoking: A clinical laboratory study.
СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wong Melissa K, Jafarzadeh Nikki S, Chasson Gregory S, Dyer Walter G, Peraza Natalia, Whaley Reid C, Anderson Marissa K, Strong David R, Bello Mariel S, Pang Raina D, Leventhal Adam M
Аннотация
Obsessive-compulsive symptoms (OCS)-repeated unwanted, intrusive anxiogenic thoughts and ritualistic distress-suppressing behaviors-are comorbid with persistent cigarette smoking. This clinical laboratory experiment tested a dual-mechanism conceptualization of OCS-smoking comorbidity, which purports that people with OCS persistently smoke because they are hypersensitive to smoking's sensorimotor-ritualistic and nicotine-pharmacologic negative reinforcing properties. Cigarette-smoking adults (n = 129) completed a baseline session to assess clinically significant OCS (yes/no), followed by four overnight tobacco-deprived 8-hr sessions involving exposure to each of four study conditions in a within-subject 2 × 2 factorial randomized design crossing a (a) sensorimotor manipulation that modeled the tobacco self-administration ritual's effects independent of nicotine (smoking very low nicotine cigarettes [VLNC] hourly vs. no smoking) and (b) pharmacologic manipulation that modeled nicotine's effects independent of tobacco self-administration (double-blind 21 mg nicotine vs. placebo transdermal patch). Experimental session outcome measures included self-reported smoking urge (range: 0-5), nicotine withdrawal symptoms (range: 0-5), physical pain (range: 0-10), and negative affect and a behavioral task assessing motivation to reinstate usual brand cigarette smoking. Consistent with hypotheses, participants with versus without clinically significant OCS were more sensitive to the urge-suppressing effects of smoking VLNCs versus no smoking (OCS × VLNC, B = -.14, 95% CI [-.24, -.04]; p = 01) and the pain-suppressing effects of nicotine versus placebo (OCS × Nicotine, B = -.14, 95% CI [-.24, -.03]; p = 02). Counter to hypotheses, participants with clinically significant OCS experienced weaker nicotine-induced withdrawal symptom suppression (OCS × Nicotine, B = .16, 95% CI [.09, .24]; p < .001). Other OCS × VLNC or OCS × Nicotine interactions were nonsignificant. Findings from this study partially support a conceptualization that OCS-smoking comorbidity is explained by a hypersensitivity to some of smoking's nicotine-pharmacologic and sensorimotor-ritualistic negative reinforcing properties (i.e., urge and pain suppression). (PsycInfo Database Record (c) 2026 APA, all rights reserved).